All In Biotech

Drug Trial Radar · NCT06104566

Global Trial in APG2575 for Patients With CLL/SLL

A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Lisaftoclax (APG-2575) in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (GLORA Study)

Last checked: Nov 19, 2026Latest source record: Jun 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Dec 20, 2023

Primary completion

Dec 31, 2026

Study completion Oct 31, 2027

Sponsor

Lead sponsor
Ascentage Pharma Group Inc.Industry
Sponsor type
Industry
First posted
Oct 27, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a global multicenter, open label, randomized, registrational phase III study to investigate the efficacy and safety of lisaftoclax in combination with BTK inhibitors in CLL/SLL patients who previously treated with BTK inhibitors

Conditions

  • CLL/SLL

Interventions

  • lisaftoclax +BTK inhibitorDrug

    lisaftolax + BTK inhibitor

  • BTK inhibitorDrug

    BTK inhibitor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PFSTime frame: 12 months

Locations

135 sites in 19 countries. Site status is shown where the registry gives one.

  • Ascentage Investigative Site

    Tuscon, Arizona · Recruiting

  • Ascentage Investigative Site

    Anaheim, California · Recruiting

  • Ascentage Investigative Site

    Jacksonville, Florida · Recruiting

  • Ascentage Investigative Site

    Miami Beach, Florida · Recruiting

  • Ascentage Investigative Site

    Peoria, Illinois · Recruiting

  • Ascentage Investigative Site

    Boston, Massachusetts · Recruiting

  • Ascentage Investigative Site

    Ann Arbor, Michigan · Recruiting

  • Ascentage Investigative Site

    Greenville, North Carolina · Recruiting

  • Ascentage Investigative Site

    Houston, Texas · Recruiting

  • Ascentage Investigative Site

    Kingswood, Texas · Recruiting

  • Ascentage Investigative Site

    Richmond, Virginia · Recruiting

  • Ascentage Investigative Site

    Gosford, Australia · Completed

  • Ascentage Investigative Site

    Perth, Australia · Completed

  • Ascentage Investigative Site

    Westmead, Australia · Completed

  • Ascentage Investigative Site

    Ghent, Belgium · Recruiting

  • Ascentage Investigative Site

    La Louvière, Belgium · Recruiting

  • Ascentage Investigative Site

    Leuven, Belgium · Recruiting

  • Ascentage Investigative Site

    Ottignies, Belgium · Recruiting

  • Ascentage Investigative Site

    Roeselare, Belgium · Recruiting

  • Ascentage Investigative Site

    Sofia, Bulgaria · Recruiting

  • Ascentage Investigative Site

    Sofia, Bulgaria · Recruiting

  • Ascentage Investigative Site

    Sofia, Bulgaria · Recruiting

  • Ascentage Investigative Site

    Sofia, Bulgaria · Recruiting

  • Ascentage Investigative Site

    Halifax, Nova Scotia, Canada · Recruiting

  • Ascentage Investigative Site

    Guangzhou, China · Recruiting

  • Ascentage Investigative Site

    Hefei, Anhui, China · Recruiting

  • Ascentage Investigative Site

    Beijing, Beijing Municipality, China · Recruiting

  • Ascentage Investigative Site

    Fuzhou, Fujian, China · Recruiting

  • Ascentage Investigative Site

    Foshan, Guangdong, China · Recruiting

  • Ascentage Investigative Site

    Guangzhou, Guangdong, China · Recruiting

  • Ascentage Investigative Site

    Nanning, Guangxie, China · Recruiting

  • Ascentage Investigative Site

    Zhengzhou, Henan, China · Recruiting

  • Ascentage Investigative Site

    Wuhan, Hubei, China · Recruiting

  • Ascentage Investigative Site

    Chenzhou, Hunan, China · Recruiting

  • Ascentage Investigative Site

    Nanjing, Jiangsu, China · Recruiting

  • Ascentage Investigative Site

    Suzhou, Jiangsu, China · Recruiting

  • Ascentage Investigative Site

    Wuxi, Jiangsu, China · Recruiting

  • Ascentage Investigative Site

    Nanchang, Jiangxi, China · Recruiting

  • Ascentage Investigative Site

    Xi'an, Shaanxi, China · Recruiting

  • Ascentage Investigative Site

    Binzhou, Shandong, China · Recruiting

Showing 40 of 135 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.